ArticleTheranostics2021

IRDye800CW labeled uPAR-targeting peptide for fluorescence-guided glioblastoma surgery: Preclinical studies in orthotopic xenografts.

Sorel Kurbegovic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.